139 related articles for article (PubMed ID: 8071711)
1. Modeling of tumor uptake to determine the time-dose-fractionation effect in radioimmunotherapy.
Liu A; Williams LE; Demidecki AJ; Raubitschek AA; Wong JY
J Nucl Med; 1994 Sep; 35(9):1561-4. PubMed ID: 8071711
[No Abstract] [Full Text] [Related]
2. Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides.
Rao DV; Howell RW
J Nucl Med; 1993 Oct; 34(10):1801-10. PubMed ID: 8410301
[TBL] [Abstract][Full Text] [Related]
3. Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.
O'Donoghue JA; Sgouros G; Divgi CR; Humm JL
J Nucl Med; 2000 Mar; 41(3):538-47. PubMed ID: 10716330
[TBL] [Abstract][Full Text] [Related]
4. [Clinical examinations on the importance of different fractionation rhythms for radiation therapy. Radiation physical model representations for optimizing fractionation conditions in radiation therapy].
Kriester A
Radiobiol Radiother (Berl); 1975; 16(4):419-23. PubMed ID: 1208825
[No Abstract] [Full Text] [Related]
5. [Tumor growth kinetics and the dynamic dose fractionation regimen].
Balmukhanov SB
Med Radiol (Mosk); 1978 Jan; 23(1):13-7. PubMed ID: 625203
[No Abstract] [Full Text] [Related]
6. [Current problems of dose-time correlation in delayed radiotherapy of cancer].
Akimov AA; Il'in NV
Vopr Onkol; 2000; 46(6):666-75. PubMed ID: 11219936
[No Abstract] [Full Text] [Related]
7. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
[TBL] [Abstract][Full Text] [Related]
8. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM
J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529
[TBL] [Abstract][Full Text] [Related]
9. [Macro-fractionation and efficacy of radiotherapy for cancer].
Kholin VV
Vopr Onkol; 1974 Oct; 20(7):103-9. PubMed ID: 4605776
[No Abstract] [Full Text] [Related]
10. [Radioimmunotherapy in the treatment of cancers].
Mahé M; Chatal JF
Bull Cancer; 1994 Sep; 81(9):788-99. PubMed ID: 7703569
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy.
Shen S; DeNardo GL; DeNardo SJ; Salako Q; Morris G; Banks D; Yuan A; DeNardo DA
J Nucl Med; 1996 Jan; 37(1):146-50. PubMed ID: 8543984
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on volume-doubling time of human malignant tumors. (The difference of radiation effect according to the different fractionation) (author's transl)].
Sugawara T
Nihon Igaku Hoshasen Gakkai Zasshi; 1976; 36(2):103-10. PubMed ID: 1063997
[No Abstract] [Full Text] [Related]
13. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
Chen Y; Geng J; Tian J; He Y; Chen S
Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
[No Abstract] [Full Text] [Related]
14. [Significance of the rhythm of macrofraction irradiation for therapeutic effect].
Arungazyeva VV; Sizenko SP
Med Radiol (Mosk); 1974 Oct; 19(10):74-6. PubMed ID: 4431304
[No Abstract] [Full Text] [Related]
15. Optimal therapeutic strategies for radioimmunotherapy.
O'Donoghue JA
Recent Results Cancer Res; 1996; 141():77-99. PubMed ID: 8722421
[No Abstract] [Full Text] [Related]
16. Tumor-targeted radionuclide therapy: trial design driven by patient dosimetry.
DeNardo SJ
J Nucl Med; 2000 Jan; 41(1):104-6. PubMed ID: 10647611
[No Abstract] [Full Text] [Related]
17. Recent advances in radiation therapy.
Gerber DE; Chan TA
Am Fam Physician; 2008 Dec; 78(11):1254-62. PubMed ID: 19069018
[TBL] [Abstract][Full Text] [Related]
18. [Studies in white rats on the biological effectiveness of the combined effect of radiation and cyclophosphamide, depending on dosage, fractionation, and the time sequence of the combination].
Schmidt W
Radiobiol Radiother (Berl); 1974; 15(2):295-302. PubMed ID: 4465830
[No Abstract] [Full Text] [Related]
19. [Clinico-radiobiological evaluation of radiation dosage and complications of radiotherapy for endometrial neoplasm metastasis to the vagina].
Kanaev SV; Turkevich VG
Vopr Onkol; 1999; 45(3):272-8. PubMed ID: 10443230
[TBL] [Abstract][Full Text] [Related]
20. [Optimization of the timing of dose distribution in radiation therapy].
Kozlov AP; Afanas'ev BP; Antonevich OV; Akimov AA
Med Radiol (Mosk); 1985 Jun; 30(6):49-52. PubMed ID: 4021753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
